Cablegate: Pharmaceutical Companies Seek Usg Help On Goe

This record is a partial extract of the original cable. The full text of the original cable is not available.




E.O. 12958: N/A

1. See action request paragraph 7.

2. Summary. Econ and FCS met November 19 with
representatives from Bristol Meyers and Pfizer. The
pharmaceutical representatives complained that the GOE is
trying to exert further control over drug prices and company
profits. This latest initiative by the Ministry of Public
Health is the second attempt in the last six months at
decreasing drug prices by limiting drug company profits.
According to the drug reps, if approved, the regulation would
adversely affect international and local drug companies in
Ecuador. Emboffs explained that Intellectual Property
Rights, particularly concerning pharmaceutical company
concerns, have been an important and sensitive part of Andean
Free Trade Agreement negotiations. We promised to seek
Washington guidance as to how to raise this issue with the
GOE. End Summary.

Another Assault on Profits

3. Pharmaceutical representatives explained to econ and
commercial section officers on November 19 that the GOE was
trying for the second time in the last six months to limit
pharmaceutical prices, this time via a Presidential decree.
Earlier this year, the GOE considered a draft law that would
have reduced the maximum profit allowed drug companies for
each individual product or presentation from 20% to 8%.
After complaints from the industry and discussions with
Emboffs, the GOE backed off from that initiative.

4. The Ministry of Public Health is behind the latest
initiative, according to the Bristol Meyers Squibb and Pfizer
representatives. Bristol Meyers' lawyer said the decree
would redefine and lower the acceptable costs of
pharmaceutical companies; thus, "artificially" inflating
company profits and forcing them to reduce prices in order to
keep under the 20% profit ceiling. Other representatives
noted that drug prices had already been frozen by the GOE for
the last two years. When questioned, they said the proposed
decree would adversely affect both international drug
companies and local generic drug producers.

A Topic for the Trade Negotiators

5. Econoffs noted that intellectual property rights (IPR),
particularly with respect to pharmaceutical products had been
an important and sensitive part of the ongoing Andean Free
Trade Agreement negotiations. Given the sensitivity, the
Embassy would request instructions from Washington before
approaching the GOE about this issue.

Comment and Action Request

6. This latest salvo from the GOE is another attempt to
address populist concerns about the price of drugs in
Ecuador. The fact that the proposed decree would adversely
impact both major pharmaceutical companies and local
producers of generic drugs means both will probably lobby
against the proposal, making issuance of the decree less
likely. Still, any GOE effort to lower drug prices would be
viewed favorably by many and the Gutierrez administration
could use all the popular support it can get. Thus, populist
concerns could win the day.

7. Action Request. Post requests guidance from Washington on
what, if any, next steps to take regarding the proposed

© Scoop Media

World Headlines


Syria: Economic Decline, Rising Hunger And Surging Humanitarian Needs

Syria’s fragile economy has “suffered multiple shocks” over the past 18 months, with its currency plummeting and joblessness swelling as people struggle to cover their basic needs, the UN Emergency Relief Coordinator told the Security Council ... More>>

OECD: Final Quarter Of 2020 Shows Continued Recovery In G20 International Merchandise Trade

G20 international merchandise trade continued to rebound in the fourth quarter of 2020 ( exports up 7.2% and imports up 6.8%), following the sharp falls seen in the first half of 2020, as lockdown measures affected trade globally. Although growth ... More>>

UN Report: Civilian Casualties Surged After Peace Talks Began In Afghanistan

Monitoring by the UN Assistance Mission in Afghanistan, UNAMA, and the UN Human Rights Office has revealed that despite a drop in civilians killed and injured overall in 2020 there was a rise in civilian casualties following the start of peace negotiations ... More>>

Focus On: UN SDGs

2021: Critical Year To ‘reset Our Relationship With Nature’ – UN Chief

During this time of “crisis and fragility”, the UN chief told the United Nations Environment Assembly on Monday that human well-being and prosperity can be vastly improved by prioritizing nature-based solutions. Painting a picture of the turmoil ... More>>

Paris Agreement: UN Secretary-General António Guterres To Mark U.S. Reentry With Envoy For Climate John Kerry

Watch live at UN Secretary-General António Guterres will join U.S. Special Presidential Envoy for Climate John F. Kerry at an event marking the United States’ reentry into the Paris Agreement this Friday. The discussion with the Secretary-General ... More>>

WeBeliev: Scoop In Conversation With Abhishek Sinha, Founder Of WeBeliev, An NZ Crowdfunding Platform

WeBeliev supports 17 SDGs, launching sector specific campaigns every month Q. What is WeBeliev and why did you start it? A. WeBeliev is a Singapore-registered crowdfunding platform aimed at fundraising for all the 17 Sustainable Development Goals (SDGs) ... More>>